de Ridder L - Search Results

1

ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.

Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, Kolho KL, Veres G, Russell RK, Paerregaard A, Buderus S, Greer ML, Dias JA, Veereman-Wauters G, Lionetti P, Sladek M, Martin de Carpi J, Staiano A, Ruemmele FM, Wilson DC; European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Levine A, et al. Among authors: de ridder l. J Pediatr Gastroenterol Nutr. 2014 Jun;58(6):795-806. doi: 10.1097/MPG.0000000000000239. J Pediatr Gastroenterol Nutr. 2014. PMID: 24231644

2

[Infliximab therapy in children and adolescents with refractory Crohn's disease in the Netherlands; experience with 23 patients].

de Ridder L, Escher JC, Taminiau JA. de Ridder L, et al. Ned Tijdschr Geneeskd. 2002 Oct 5;146(40):1879-83. Ned Tijdschr Geneeskd. 2002. PMID: 12395595 Dutch.

3

Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands.

de Ridder L, Escher JC, Bouquet J, Schweizer JJ, Rings EH, Tolboom JJ, Houwen RH, Norbruis OF, Derkx BH, Taminiau JA. de Ridder L, et al. J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):46-52. doi: 10.1097/00005176-200407000-00010. J Pediatr Gastroenterol Nutr. 2004. PMID: 15187780

4

Pharmacogenetics of thiopurine therapy in paediatric IBD patients.

De Ridder L, Van Dieren JM, Van Deventer HJ, Stokkers PC, Van der Woude JC, Van Vuuren AJ, Benninga MA, Escher JC, Hommes DW. De Ridder L, et al. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1137-41. doi: 10.1111/j.1365-2036.2006.02853.x. Aliment Pharmacol Ther. 2006. PMID: 16611274 Free article.

5

Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease.

Jaspers GJ, Verkade HJ, Escher JC, de Ridder L, Taminiau JA, Rings EH. Jaspers GJ, et al. Among authors: de ridder l. Inflamm Bowel Dis. 2006 Sep;12(9):831-6. doi: 10.1097/01.mib.0000232470.00703.67. Inflamm Bowel Dis. 2006. PMID: 16954801

6

Infliximab use in children and adolescents with inflammatory bowel disease.

de Ridder L, Benninga MA, Taminiau JA, Hommes DW, van Deventer SJ. de Ridder L, et al. J Pediatr Gastroenterol Nutr. 2007 Jul;45(1):3-14. doi: 10.1097/MPG.0b013e31803e171c. J Pediatr Gastroenterol Nutr. 2007. PMID: 17592358 Review.

7

Infliximab dependency in pediatric Crohn's disease: long-term follow-up of an unselected cohort.

de Ridder L, Rings EH, Damen GM, Kneepkens CM, Schweizer JJ, Kokke FT, Benninga MA, Norbruis OF, Hoekstra JH, Gijsbers CF, Escher JC. de Ridder L, et al. Inflamm Bowel Dis. 2008 Mar;14(3):353-8. doi: 10.1002/ibd.20329. Inflamm Bowel Dis. 2008. PMID: 18069674

8

Percutaneous endoscopic gastrostomy (PEG) in children is not a minor procedure: risk factors for major complications.

Vervloessem D, van Leersum F, Boer D, Hop WC, Escher JC, Madern GC, de Ridder L, Bax KN. Vervloessem D, et al. Among authors: de ridder l. Semin Pediatr Surg. 2009 May;18(2):93-7. doi: 10.1053/j.sempedsurg.2009.02.006. Semin Pediatr Surg. 2009. PMID: 19348998

9

Magnetic resonance enterography for suspected inflammatory bowel disease in a pediatric population.

Horsthuis K, de Ridder L, Smets AM, van Leeuwen MS, Benninga MA, Houwen RH, Littooij AS, Nievelstein RA, Stoker J. Horsthuis K, et al. Among authors: de ridder l. J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):603-9. doi: 10.1097/MPG.0b013e3181dee5bd. J Pediatr Gastroenterol Nutr. 2010. PMID: 20890223

10

[Guideline 'Diagnosis and treatment of inflammatory bowel disease in children'].

de Ridder L, Rings EH, Escher JC; CBO-werkgroep ‘IBD bij kinderen’. de Ridder L, et al. Ned Tijdschr Geneeskd. 2010;154:A1898. Ned Tijdschr Geneeskd. 2010. PMID: 21029495 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page